Oxidative stress triggers Itch-mediated TXNIP degradation and NF-κB activation promoting chronic obstructive

Pei-Yun Lin1,2, Kang-Yun Lee3,4,5,6, Shu-Chuan Ho2,5

  • 1Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei , 110, Taiwan.

Respiratory Research
|October 17, 2025
PubMed
Abstract

Insights

Cigarette smoke triggers oxidative stress, leading to Itch-mediated degradation of TXNIP. This process activates NF-κB, driving inflammation in macrophages and contributing to chronic obstructive pulmonary disease (COPD) development.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Molecular Biology

Background:

  • Chronic inflammatory lung diseases like COPD involve lung structural changes and airway narrowing due to persistent inflammation.
  • Macrophage-mediated inflammation is crucial in COPD pathogenesis, but the mechanisms driving sustained inflammation are not fully understood.

Purpose of the Study:

  • To investigate the role of thioredoxin-interacting protein (TXNIP) in cigarette smoke-induced pulmonary inflammation.
  • To elucidate the molecular mechanisms underlying TXNIP regulation and its contribution to COPD pathogenesis.

Main Methods:

  • In vitro studies used RAW264.7 macrophages treated with cigarette smoke extract (CSE), hydrogen peroxide, and MAPK inhibitors.
  • Loss-of-function assays included Itch-specific knockdown.
  • In vivo studies analyzed lung tissues from mice exposed to cigarette smoke (CS) and clinical samples from healthy individuals and COPD patients.

Main Results:

  • Cigarette smoke extract (CSE) inhibited TXNIP expression in macrophages via MAPK-dependent pathways, increasing iNOS/NO and COX-2.
  • CS-induced oxidative stress promoted proteasomal degradation of TXNIP, mediated by the E3 ligase Itch, leading to NF-κB activation and inflammation.
  • Reduced TXNIP and increased Itch expression were observed in lung tissues and cells from smoking mice and COPD patients.

Conclusions:

  • Cigarette smoke-induced oxidative stress promotes Itch-mediated degradation of TXNIP.
  • This degradation activates NF-κB signaling in macrophages, contributing to pulmonary inflammation.
  • The Itch-TXNIP-NF-κB pathway represents a potential therapeutic target for COPD.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.8K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K